Overview

A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia
Phase:
Phase 4
Details
Lead Sponsor:
Cumberland Pharmaceuticals
Treatments:
Conivaptan